RESUMEN
It is a common practice to provide fast-growing broilers with high-fat diets in the context of integrated farms in Northeast China. Therefore, fat digestion, absorption, and utilization efficiency are critical for broiler meat production. Bile acids (BA) promote fat digestion and absorption, but whether and how BA affects muscle growth in broilers remains unclear. In this study, 1-day-old broilers were fed diets containing varying levels of crude fat (low, medium, and high) with or without BA supplementation for 42 d. Chickens fed a high-fat diet supplemented with BA exhibited significantly (P < 0.05) higher body weight (BW) at 21 d and average daily gain (ADG) during the first 21 d compared to the other groups. Throughout the entire experiment, feed conversion rate (FCR) was significantly (P < 0.05) lower in the high-fat group without the addition of BA, which was further decreased (P < 0.05) with BA supplementation. The improved growth performance in the BA-supplemented high-fat group was associated with significantly (P < 0.05) higher lipase activity in the small intestine chyme, a decreased trend (P = 0.06) in abdominal fat ratio, and significantly (P < 0.05) higher breast muscle mass. Histological analysis revealed significant (P < 0.05) increases in myofiber diameter, cross-sectional area, and RNA and DNA concentrations in the breast muscle of BA-supplemented broilers on the high-fat diet. Additional histological analysis further revealed significant (P < 0.05) enhancements in myofiber diameter, cross-sectional area, and RNA and DNA concentrations within the breast muscles of broilers supplemented with BA and a high-fat diet. The increased insulin-like growth factor 2 (IGF2) in the breast muscle of broilers fed a BA-supplemented high-fat diet correlated with significantly (P < 0.05) increased farnesoid X factor (FXR) protein expression and binding to the IGF2 promoter. These results suggest that dietary BA supplementation improves FCR and breast muscle growth in broilers fed a high-fat diet, potentially through the FXR-mediated IGF2 pathway.
Asunto(s)
Ácidos y Sales Biliares , Pollos , Animales , Pollos/fisiología , Dieta/veterinaria , Suplementos Dietéticos/análisis , Dieta Alta en Grasa , Músculos Pectorales , ADN , ARN , Alimentación Animal/análisis , Fenómenos Fisiológicos Nutricionales de los AnimalesRESUMEN
BACKGROUND: Pain in amyotrophic lateral sclerosis (ALS) has a considerable impact on the quality of life of both patients and their caregivers, and thus the identification and evaluation of pain characteristics in ALS should be addressed. However, due to the scarcity of research data, pain in ALS is still frequently underestimated and insufficiently treated. The aim of this study was to investigate the characteristics of pain in patients with ALS using standardized pain questionnaires. METHODS: Eighty-nine patients diagnosed with ALS were interviewed. Consecutive patients with peripheral neuropathy were used as control subjects and were matched to the ALS subjects by age and sex. Patient data including gender, age, the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) score, and the pain severity index (PSI) were collected. The characteristics between ALS and peripheral neuropathy, and between ALS patients with and without pain were compared. RESULTS: In all, 89 patients with ALS and 89 control subjects with peripheral neuropathy were included. There were no significant differences in sex ratio and age between the two groups. There were significantly more patients with pain symptoms in the ALS group (35/89, 39%) than in the peripheral neuropathy group (20/89, 22%). Quality of life was significantly affected in the ALS patients with pain (using ALS patients without pain as control subjects). CONCLUSIONS: The results suggested that pain was a significant symptom in patients with ALS and had a considerable impact on quality of life.
Asunto(s)
Esclerosis Amiotrófica Lateral , Calidad de Vida , China , Humanos , Dolor/etiología , Encuestas y CuestionariosRESUMEN
The aim of the present study was to investigate the protective effect of granulocyte colony-stimulating factor (G-CSF) on acute ischemic cerebral injury, and its mechanism through the impact of G-CSF on early growth response-1 (Egr-1) and vascular endothelial growth factor (VEGF) expressions. Male Sprague-Dawley (SD) rats were divided them into three groups, i.e., the sham, model and G-CSF groups to measure the effect of G-CSF on the volume of cerebral infarction and level of lactate dehydrogenase (LDH) in rats. Hematoxylin and eosin (H&E) staining method was performed for histopathological examination. Reverse transcription-polymerase chain reaction (RT-PCR) and western blot analysis were used to detect the mRNA and protein expressions of Egr-1 and VEGF in different groups. Furthermore, Statistical Product and Service Solutions (SPSS) 17.0 software was applied to detect the differences in the expression of Egr-1 and VEGF between the two groups. Compared with the sham group, we found that the volume of cerebral infarction and LDH content in the model group were significantly elevated. By contrast, in the model group, those indicators in the G-CSF group were obviously decreased. H&E staining results also showed that G-CSF could decrease the necrotic area in cerebral infarction and the incidence of inflammation, and sustain the integrity of the molecular structure. Immunofluorescence staining results revealed that the protein expressions of Egr-1 and VEGF in the model group were all significantly decreased, while those in the G-CSF group were remarkably elevated. RT-PCR and western blot analysis revealed that the mRNA and protein expressions of Egr-1 and VEGF in the model group were decreased obviously, but those in the G-CSF group were elevated significantly, and the differences between the two groups showed statistical significance (P<0.05). G-CSF manifests a significant protective effect on the acute ischemic cerebral injury, which may be realized through its effect on the expressions of Egr-1 and VEGF.